Dianthus Therapeutics Stock Market Value
| DNTH Stock | 20.27 0.50 2.41% |
| Symbol | Dianthus |
Dianthus Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 7.22 | Revenue Per Share 0.19 | Quarterly Revenue Growth 1.351 | Return On Assets (0.19) | Return On Equity (0.26) |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dianthus Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dianthus Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dianthus Therapeutics.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Dianthus Therapeutics on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Dianthus Therapeutics or generate 0.0% return on investment in Dianthus Therapeutics over 720 days. Dianthus Therapeutics is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Dianthus Therapeutics is entity of United States More
Dianthus Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dianthus Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dianthus Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 16.65 | |||
| Value At Risk | (6.74) | |||
| Potential Upside | 5.7 |
Dianthus Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dianthus Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dianthus Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dianthus Therapeutics historical prices to predict the future Dianthus Therapeutics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.31) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dianthus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dianthus Therapeutics Backtested Returns
Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.15, which denotes the company had a -0.15% return per unit of standard deviation over the last 3 months. Dianthus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dianthus Therapeutics' Standard Deviation of 3.65, mean deviation of 2.79, and Coefficient Of Variation of (834.04) to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.44, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dianthus Therapeutics will likely underperform. At this point, Dianthus Therapeutics has a negative expected return of -0.54%. Please make sure to confirm Dianthus Therapeutics' potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Dianthus Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.34 |
Below average predictability
Dianthus Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Dianthus Therapeutics time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dianthus Therapeutics price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Dianthus Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 36.76 |
Dianthus Therapeutics lagged returns against current returns
Autocorrelation, which is Dianthus Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dianthus Therapeutics' stock expected returns. We can calculate the autocorrelation of Dianthus Therapeutics returns to help us make a trade decision. For example, suppose you find that Dianthus Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dianthus Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dianthus Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dianthus Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dianthus Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Dianthus Therapeutics Lagged Returns
When evaluating Dianthus Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dianthus Therapeutics stock have on its future price. Dianthus Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dianthus Therapeutics autocorrelation shows the relationship between Dianthus Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Dianthus Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Dianthus Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dianthus Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dianthus Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dianthus Therapeutics Stock:Check out Dianthus Therapeutics Correlation, Dianthus Therapeutics Volatility and Dianthus Therapeutics Alpha and Beta module to complement your research on Dianthus Therapeutics. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.